Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 12, 2008, Pages 4463-4465

  Sato, Hiromi ^a   Feix, Jimmy B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CM 15; K 10; K 1014; K 14; K 4; K 410; K 414; LYSINE; LYSYLTRYPTOPHYLLYSYLLEUCYLPHENYLALANYLLYSYLLYSYLISOLEUCYL GLYCYLALANYLVALYLLEUCYLLYSYLLYSYLLEUCINE; LYSYLTRYPTOPHYLLYSYLLEUCYLPHENYLALANYLLYSYLLYSYLISOLEUCYL GLYCYLALANYLVALYLLEUCYLLYSYLVALYLLEUCINE; LYSYLTRYPTOPHYLLYSYLLEUCYLPHENYLALANYLLYSYLLYSYLISOLEUCYL GLYCYLLYSYLVALYLLEUCYLLYSYLLYSYLLEUCINE; LYSYLTRYPTOPHYLLYSYLLEUCYLPHENYLALANYLLYSYLLYSYLISOLEUCYLGLYCYL LYSYLVALYLLEUCYLLYSYLVALYLLEUCINE; LYSYLTRYPTOPHYLLYSYLLYSYLPHENYLALANYLLYSYLLYSYLISOLEUCYL GLYCYLALANYLVALYLLEUCYLLYSYLLYSYLLEUCINE; LYSYLTRYPTOPHYLLYSYLLYSYLPHENYLALANYLLYSYLLYSYLISOLEUCYL GLYCYLALANYLVALYLLEUCYLLYSYLVALYLLEUCINE; LYSYLTRYPTOPHYLLYSYLLYSYLPHENYLALANYLLYSYLLYSYLISOLEUCYL GLYCYLLYSYLVALYLLEUCYLLYSYLVALYLLEUCINE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG SELECTIVITY; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; GRAM-NEGATIVE BACTERIA; HEMOLYSIS; HUMANS; LYSINE; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY; STAPHYLOCOCCUS;

EID: 57049114502     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00810-08     Document Type: Article

References (22)

1. Alberola, J., A. Rodriguez, O. Francino, X. Roura, L. Rivas, and D. Andreu. 2004. Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. Antimicrob. Agents Chemother. 48:641-643.
2. Andreu, D., J. Ubach, A. Boman, B. Wahlin, D. Wade, R. B. Merrifield, and H. G. Boman. 1992. Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Lett. 296:190-194.
3. Bhargava, K., and J. B. Feix. 2004. Membrane binding, structure, and localization of cecropin-mellitin hybrid peptides: a site-directed spin-labeling study. Biophys. J. 86:329-336.
4. Blondelle, S. E., J. M. Ostresh, R. A. Houghten, and E. Perez-Paya. 1995. Induced conformational states of amphipathic peptides in aqueous/lipid environments. Biophys. J. 68:351-359.
5. Boman, H. G., D. Wade, I. A. Boman, B. Wahlin, and R. B. Merrifield. 1989. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett. 259:103-106.
6. Brogden, K. A., J. M. Guthmiller, M. Salzet, and M. Zasloff. 2005. The nervous system and innate immunity: the neuropeptide connection. Nat. Immunol. 6:558-564.
7. Chicharro, C., C. Granata, R. Lozano, D. Andreu, and L. Rivas. 2001. N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide. Antimicrob. Agents Chemother. 45:2441-2449.
8. Dathe, M., and T. Wieprecht. 1999. Structural features of helical antimicrobial peptides. Biochim. Biophys. Acta 1462:71-87.
9. Epand, R. M., and H. J. Vogel. 1999. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462:11-28.
10. Giacometti, A., O. Cirioni, W. Kamysz, G. D'Amato, C. Silvestri, M. Simona Del Prete, J. Lukasiak, and G. Scalise. 2004. In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. Diagn. Microbiol. Infect. Dis. 49:197-200.
11. Giangaspero, A., L. Sandri, and A. Tossi. 2001. Amphipathic alpha-helical antimicrobial peptides. Eur. J. Biochem. 268:5589-5600.
12. Holak, T. A., A. Engstrom, P. J. Kraulis, G. Lindeberg, H. Bennich, T. A. Jones, A. M. Gronenborn, and G. M. Clore. 1988. The solution conformation of the antibacterial peptide cecropin A: a nuclear magnetic resonance and dynamical simulated annealing study. Biochemistry 27:7620-7629.
13. Jenssen, H., P. Hamill, and R. E. W. Hancock. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511.
14. Juvvadi, P., S. Vunnam, E. L. Merrifield, H. G. Boman, and R. B. Merrifield. 1996. Hydrophobic effects on antibacterial and channel-forming properties of cecropin A-melittin hybrids. J. Pep. Sci. 2:223-232.
15. Pistolesi, S., R. Pogni, and J. B. Feix. 2007. Membrane insertion and bilayer perturbation by antimicrobial peptide CM15. Biophys. J. 93:1651-1660.
16. Sato, H., and J. B. Feix. 2006. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides. Biochim. Biophys. Acta 1758:1245-1256.
17. Sato, H., and J. B. Feix. 2006. Osmoprotection of bacterial cells from toxicity caused by antimicrobial hybrid peptide CM15. Biochemistry 45:9997-10007.
18. Saugar, J. M., M. J. Rodriguez-Hernandez, B. G. de la Torre, M. E. Pachon-Ibanez, M. Fernandez-Reyes, D. Andreu, J. Pachon, and L. Rivas. 2006. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action. Antimicrob. Agents Chemother. 50:1251-1256.
19. Sipos, D., M. Andersson, and A. Ehrenberg. 1992. The structure of the mammalian antibacterial peptide cecropin P1 in solution, determined by proton-NMR. Eur. J. Biochem. 209:163-169.
20. Sipos, D., K. Chandrasekhar, K. Arvidsson, A. Engstrom, and A. Ehrenberg. 1991. Two-dimensional proton-NMR studies on a hybrid peptide between cecropin A and melittin. Resonance assignments and secondary structure. Eur. J. Biochem. 199:285-291.
21. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
22. Zelezetsky, I., and A. Tossi. 2006. Alpha-helical antimicrobial peptides: using a sequence template to guide structure-activity relationship studies. Biochim. Biophys. Acta 1758:1436-1449.